ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Sutro Biopharma (STRO) Technical (Analysis) Reports Sutro Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Sutro Biopharma (STRO)

Technical Analysis Report for NASDAQ stock STRO Sutro Biopharma. Dated: 12 May 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock STRO Sutro Biopharma then click here. or read Experts views on Sutro Biopharma or Forecast & share price targets of Sutro Biopharma

Sutro Biopharma Opened at 38.80 and Closed at: 40.91, which is 3.91% of previous session's close. It moved within a range of 37.73 and 41.26
The session was a Bullish session with an average volume of 224600, which is 11.75% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 39.32 and resistance for tomorrow is 42.85
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 38.67, 36.44 resistance for tomorrow's hourly charts is 42.2, 43.5

10 Day SMA for Sutro Biopharma (STRO) is 38.36 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Sutro Biopharma (STRO) is 36.04 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Sutro Biopharma (STRO) is 28.99 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 21.76 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Sutro Biopharma is 11.79 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Sutro Biopharma is at 36.04 and 200 DMA is at 11.79, while 50 DMA and 100 DMA are at 28.99 and 21.76 respectively

Sutro Biopharma (STRO) moving average of 20 SMA is at 36.04 and 20 EMA is at 35.83

Sutro Biopharma (STRO) moving average of 50 SMA is at 28.99 and 50 EMA is at 29.94

Sutro Biopharma (STRO) moving average of 100 SMA is at 21.76 and 100 EMA is at 23.34

Sutro Biopharma (STRO) moving average of 200 SMA is at 11.79 and 200 EMA is at 16.13

Sutro Biopharma has performed better than Vtv Therapeutics in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Vertex Pharmaceuticals in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Trinity Biotech in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Puma Biotechnology in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Kamada in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Iridex Corporation in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Inovio Pharmaceuticals in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Immutep in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Integra Lifesciences in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Geron Corporation in short term. Holding Sutro Biopharma could be a better choice for now!

Fate Therapeutics has performed better than Sutro Biopharma in short term. You could have earned much better returns by investing in Fate Therapeutics, about 24.84% more returns!

Sutro Biopharma has performed better than Electrocore Inc in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Cytokinetics Incorporated in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Curis Inc in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Celldex Therapeutics in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Array Biopharma in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Amarin Corporation in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma has performed better than Allogene Therapeutics in short term. Holding Sutro Biopharma could be a better choice for now!

Sutro Biopharma Technical analysis of indicators

Price action analysis of Sutro Biopharma (STRO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Sutro Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Sutro Biopharma in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Sutro Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Sutro Biopharma in short term and BUY signal is strong.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Sutro Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 38.39 and Sutro Biopharma STRO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Sutro Biopharma STRO stock. Volume based technical analysis of Sutro Biopharma STRO stock is negative.

Sutro Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock STRO Sutro Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And STRO Experts View which covers a lot of information including buying and selling signals

STRO future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sutro Biopharma or View Candle Stick Charts here

Chart Sutro Biopharma (STRO)  Technical (Analysis) Reports Sutro Biopharma [

Videos related to: Sutro Biopharma (STRO) Technical (Analysis) Reports Sutro Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Sutro Biopharma (STRO)  Technical (Analysis) Reports Sutro Biopharma [

 

Back to top